Bayesian network enables interpretable and state-of-the-art prediction of immunotherapy responses in cancer patients
Hideki Hozumi, View ORCID ProfileHideyuki Shimizu
doi: https://doi.org/10.1101/2022.11.02.22281835
Hideki Hozumi
1Keio University School of Medicine, Tokyo 160-8582, Japan
Hideyuki Shimizu
2Department of AI Systems Medicine, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo 113-8510, Japan
Article usage
Posted November 07, 2022.
Bayesian network enables interpretable and state-of-the-art prediction of immunotherapy responses in cancer patients
Hideki Hozumi, Hideyuki Shimizu
medRxiv 2022.11.02.22281835; doi: https://doi.org/10.1101/2022.11.02.22281835
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (204)
- Emergency Medicine (372)
- Epidemiology (11629)
- Forensic Medicine (10)
- Gastroenterology (684)
- Genetic and Genomic Medicine (3636)
- Geriatric Medicine (342)
- Health Economics (623)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3392)
- Nursing (193)
- Nutrition (512)
- Oncology (1782)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6030)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)